Market Research Logo

Europe Gerd Drugs And Devices Market Forecast 2019-2027

Europe Gerd Drugs And Devices Market Forecast 2019-2027

KEY FINDINGS

In 2016, the European market for GERD drugs and devices have been accounted as the largest market worldwide, expected to grow with 0.93% CAGR during the forecasted period 2019-2027.

MARKET INSIGHTS

The chances of GERD among patients coming for diagnosis at least once per week is in the range of 8.8–25.9 % in Europe which demonstrates the presence of a large number of patients suffering from GERD in this region. Awareness about GERD and usage of self-medication is promoting the growth of the GERD drugs and devices market in Europe.

Germany and Spain are found to be the largest contributors to the European GERD drugs and devices market because of negative factors like a high share of out-of-pocket spending and inadequate numbers of health professionals are still enhancing the rate of GERD occurrence being untreated.

COMPETITIVE INSIGHTS

The key market players that are rigorously developing newer drugs and expanding their bases for individual market revenue increment are Abbott Laboratories, AstraZeneca, Ausch Health (Formerly Valeant Pharmaceuticals International, Inc.), Boston Scientific Corporation, Cempra Inc. (Merged with Melinta), Daewoong Co. Ltd., Eisai Inc., Glaxosmithkline, Ironwood Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer, Inc., RaQualia Pharma Inc. and Takeda Pharmaceuticals Company Limited.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Antacids Drug Class Holds The Largest Market Share
3.2.2. Bravo System Devices Are Widely Used
4. Market Dynamics
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Growing Trend Of Self-medication
4.2.2. Increasing Awareness About Gerd
4.2.3. Increasing Occurrence Of Gerd Disorders
4.2.4. Changes In Lifestyle
4.3. Market Restraints
4.3.1. Patent Expiry
4.3.2. Adverse Effect Of Proton Pump Inhibitors And Other Drugs
4.3.3. Proton Pump Inhibitor Resistance
4.4. Market Opportunities
4.4.1. Increased Practice Of Generics And Otc Drugs
4.4.2. Cost-effective Otc Drugs
4.4.3. Overuse Of Medication And Dietary Supplements
4.5. Market Challenges
4.5.1. Use Of Complementary And Alternative Treatments
4.5.2. Probability Of Buying Counterfeit Drugs
4.6. Market By Drugs Dosage Form
4.7. Market By Route Of Administration Of Drugs
5. Market By Drugs And Devices
5.1. Drug Class
5.1.1. Antacids
5.1.2. H2 Receptor Blockers
5.1.3. Proton Pump Inhibitors (Ppi)
5.1.4. Pro-kinetic Agents
5.2. Devices
5.2.1. Digitrapper
5.2.2. Bravo System
5.2.3. Stretta
5.2.4. Linx Reflux Management System
5.2.5. Muse (Medigus Ultrasonic Surgical Endostapler) System
5.2.6. Other Devices
6. Key Analytics
6.1. Porter’s Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute
6.1.3. Bargaining Power Of Suppliers
6.1.4. Bargaining Power Of Buyers
6.1.5. Threat Of Competitive Rivalry
6.2. Pipeline Drugs
6.3. Regulatory Framework
6.4. Patent Analysis
6.5. Opportunity Matrix
7. Geographical Analysis
7.1. Europe
7.1.1. The United Kingdom
7.1.2. Germany
7.1.3. France
7.1.4. Italy
7.1.5. Spain
7.1.6. Rest Of Europe
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Abbott Laboratories.
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Scot Analysis
8.2.1.4. Strategic Initiatives
8.2.2. Astrazeneca
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Scot Analysis
8.2.2.4. Strategic Initiatives
8.2.3. Bausch Health (Formerly Valeant Pharmaceuticals International, Inc.)
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Scot Analysis
8.2.3.4. Strategic Initiatives
8.2.4. Boston Scientific Corporation
8.2.4.1. Company Overview
8.2.4.2. Product Portfolio
8.2.4.3. Scot Analysis
8.2.4.4. Strategic Initiatives
8.2.5. Cempra Inc. (Merged With Melinta)
8.2.5.1. Company Overview
8.2.5.2. Product Portfolio
8.2.5.3. Scot Analysis
8.2.5.4. Strategic Initiatives
8.2.6. Daewoong Co. Ltd.
8.2.6.1. Company Profiles
8.2.6.2. Product Portfolio
8.2.6.3. Strategic Initiatives
8.2.7. Eisai Inc
8.2.7.1. Company Overview
8.2.7.2. Product Portfolio
8.2.7.3. Scot Analysis
8.2.7.4. Strategic Initiatives
8.2.8. Glaxosmithkline
8.2.8.1. Company Overview
8.2.8.2. Product Portfolio
8.2.8.3. Scot Analysis
8.2.8.4. Strategic Initiatives
8.2.9. Ironwood Pharmaceuticals, Inc.
8.2.9.1. Company Overview
8.2.9.2. Product Portfolio
8.2.9.3. Scot Analysis
8.2.9.4. Strategic Initiatives
8.2.10. Johnson & Johnson
8.2.10.1. Company Overview
8.2.10.2. Product Portfolio
8.2.10.3. Scot Analysis
8.2.10.4. Strategic Initiatives
8.2.11. Merck & Co., Inc.
8.2.11.1. Company Profiles
8.2.11.2. Product Portfolio
8.2.11.3. Scot Analysis
8.2.11.4. Strategic Initiatives
8.2.12. Novartis
8.2.12.1. Company Overview
8.2.12.2. Product Portfolio
8.2.12.3. Scot Analysis
8.2.12.4. Strategic Initiatives
8.2.13. Pfizer, Inc.
8.2.13.1. Company Profiles
8.2.13.2. Product Portfolio
8.2.13.3. Scot Analysis
8.2.13.4. Strategic Initiatives
8.2.14. Raqual Ia Pharma Inc.
8.2.14.1. Company Overview
8.2.14.2. Product Portfolio
8.2.14.3. Strategic Initiatives
8.2.15. Takeda Pharmaceuticals Company Limited
8.2.15.1. Company Overview
8.2.15.2. Product Portfolio
8.2.15.3. Scot Analysis
8.2.15.4. Strategic Initiatives
List Of Table
Table 1 Europe Gerd Drugs And Devices Market 2019-2027 ($ Million)
Table 2 Europe Gerd Drugs And Devices Market By Drugs And Devices 2019-2027 ($ Million)
Table 3 Europe Drug Class Market By Types 2019-2027 ($ Million)
Table 4 Europe Drug Class Market 2019-2027 ($ Million)
Table 5 Europe Antacids Market 2019-2027 ($ Million)
Table 6 Europe H2 Receptor Blockers Market 2019-2027 ($ Million)
Table 7 Europe H2 Receptor Blockers Market By Types 2019-2027 ($ Million)
Table 8 Europe Proton Pump Inhibitors (Ppi) Market 2019-2027 ($ Million)
Table 9 Europe Proton Pump Inhibitors (Ppi) Market By Types 2019-2027 ($ Million)
Table 10 Europe Pro-kinetic Agents Market 2019-2027 ($ Million)
Table 11 Europe Devices Market By Types 2019-2027 ($ Million)
Table 12 Europe Devices Market 2019-2027 ($ Million)
Table 13 Europe Digitrapper Market 2019-2027 ($ Million)
Table 14 Europe Bravo System Market 2019-2027 ($ Million)
Table 15 Europe Stretta (Mederitherapeutics) Market 2019-2027 ($ Million)
Table 16 Europe Linx® Reflux Management System (Torax Medical) Market 2019-2027 ($ Million)
Table 17 Europe Muse™ (Medigus Ultrasonic Surgical Endostapler) System Market 2019-2027 ($ Million)
Table 18 Europe Other Devices Market 2019-2027 ($ Million)
Table 19 Europe Gerd Drugs And Devices Market 2019-2027 ($ Million)
Table 20 Europe Gerd Drugs And Devices Market By Country 2019-2027 ($ Million)
List Of Figures
Figure 1 Europe Gerd Drugs And Devices Market By Geography 2019-2027 ($ Million)
Figure 2 Europe Gerd Drugs And Devices Market Share By Drugs And Devices 2017 & 2027 (%)
Figure 3 Porter’s Five Force Model
Figure 4 Europe Gerd Drugs And Devices Market Regional Outlook 2018 & 2027 (%)
Figure 5 The United Kingdom Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 6 Germany Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 7 France Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 8 Italy Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 9 Spain Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 10 Rest Of Europe Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 11 Gerd Ppis Drugs Provider Company Market Share 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report